187 related articles for article (PubMed ID: 22462706)
21. Management of subependymal giant cell tumors in tuberous sclerosis complex: the neurosurgeon's perspective.
Berhouma M
World J Pediatr; 2010 May; 6(2):103-10. PubMed ID: 20490765
[TBL] [Abstract][Full Text] [Related]
22. Imaging characteristics and growth of subependymal giant cell astrocytomas.
Clarke MJ; Foy AB; Wetjen N; Raffel C
Neurosurg Focus; 2006 Jan; 20(1):E5. PubMed ID: 16459995
[TBL] [Abstract][Full Text] [Related]
23. The burden of subependymal giant cell astrocytomas associated with tuberous sclerosis complex: results of a patient and caregiver survey.
Skalicky AM; Rentz AM; Liu Z; Wheless JW; Pelletier CL; Dunn DW; Frost MD; Nakagawa J; Magestro M; Prestifilippo J; Pashos C
J Child Neurol; 2015 Apr; 30(5):563-9. PubMed ID: 24667738
[TBL] [Abstract][Full Text] [Related]
24. Pineal region giant cell astrocytoma associated with tuberous sclerosis: case report.
Dashti SR; Robinson S; Rodgers M; Cohen AR
J Neurosurg; 2005 Apr; 102(3 Suppl):322-5. PubMed ID: 15881760
[TBL] [Abstract][Full Text] [Related]
25. Subependymal giant cell astrocytoma: a clinical, pathological, and flow cytometric study.
Shepherd CW; Scheithauer BW; Gomez MR; Altermatt HJ; Katzmann JA
Neurosurgery; 1991 Jun; 28(6):864-8. PubMed ID: 2067610
[TBL] [Abstract][Full Text] [Related]
26. Age-related changes of susceptibility-weighted imaging in subependymal nodules of neonates and children with tuberous sclerosis complex.
Niwa T; Aida N; Fujii Y; Nozawa K; Imai Y
Brain Dev; 2015 Nov; 37(10):967-73. PubMed ID: 25907013
[TBL] [Abstract][Full Text] [Related]
27. The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
Weidman DR; Palasamudram S; Zak M; Whitney R; McCoy B; Bouffet E; Taylor M; Shroff M; Bartels U
J Neurooncol; 2020 May; 147(3):731-736. PubMed ID: 32285309
[TBL] [Abstract][Full Text] [Related]
28. Tuberous sclerosis - neurosurgical indications in intraventricular tumors.
Holanda FJ; Holanda GM
Neurosurg Rev; 1980; 3(2):139-50. PubMed ID: 7231685
[TBL] [Abstract][Full Text] [Related]
29. Recurrent meningitis associated with frontal sinus tuber encephalocele in a patient with tuberous sclerosis.
Elbabaa SK; Riggs AD; Saad AG
J Neurosurg Pediatr; 2011 Jul; 8(1):103-6. PubMed ID: 21721896
[TBL] [Abstract][Full Text] [Related]
30. Subependymal nodules, giant cell astrocytomas and the tuberous sclerosis complex: a population-based study.
O'Callaghan FJ; Martyn CN; Renowden S; Noakes M; Presdee D; Osborne JP
Arch Dis Child; 2008 Sep; 93(9):751-4. PubMed ID: 18456692
[TBL] [Abstract][Full Text] [Related]
31. Dose-level response rates of mTor inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
Weidman DR; Pole JD; Bouffet E; Taylor MD; Bartels U
Pediatr Blood Cancer; 2015 Oct; 62(10):1754-60. PubMed ID: 25929843
[TBL] [Abstract][Full Text] [Related]
32. Absence of subependymal nodules in patients with tubers suggests possible neuroectodermal mosaicism in tuberous sclerosis complex.
Boronat S; Caruso P; Thiele EA
Dev Med Child Neurol; 2014 Dec; 56(12):1207-1211. PubMed ID: 24954233
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature.
Adriaensen ME; Schaefer-Prokop CM; Stijnen T; Duyndam DA; Zonnenberg BA; Prokop M
Eur J Neurol; 2009 Jun; 16(6):691-6. PubMed ID: 19236458
[TBL] [Abstract][Full Text] [Related]
34. Electrocorticographic evidence of perituberal cortex epileptogenicity in tuberous sclerosis complex.
Ma TS; Elliott RE; Ruppe V; Devinsky O; Kuzniecky R; Weiner HL; Carlson C
J Neurosurg Pediatr; 2012 Nov; 10(5):376-82. PubMed ID: 22998031
[TBL] [Abstract][Full Text] [Related]
35. Subependymal giant cell astrocytoma: a lesion with activated mTOR pathway and constant expression of glutamine synthetase.
Buccoliero AM; Caporalini C; Giordano F; Mussa F; Scagnet M; Moscardi S; Baroni G; Genitori L; Taddei GL
Clin Neuropathol; 2016; 35(5):295-301. PubMed ID: 27390104
[TBL] [Abstract][Full Text] [Related]
36. [Neurosurgical aspects in the treatment of children with tuberous sclerosis complex].
Roth J; Fried I; Constantini S
Harefuah; 2014 Jan; 153(1):43-7, 63. PubMed ID: 24605407
[TBL] [Abstract][Full Text] [Related]
37. Subependymal giant cell astrocytoma (SEGA): Is it an astrocytoma? Morphological, immunohistochemical and ultrastructural study.
Buccoliero AM; Franchi A; Castiglione F; Gheri CF; Mussa F; Giordano F; Genitori L; Taddei GL
Neuropathology; 2009 Feb; 29(1):25-30. PubMed ID: 18564101
[TBL] [Abstract][Full Text] [Related]
38. Significance of tuber size for complications of tuberous sclerosis complex.
Pascual-Castroviejo I; Hernández-Moneo JL; Pascual-Pascual SI; Viaño J; Gutiérrez-Molina M; Velazquez-Fragua R; Quiñones Tapia D; Morales Bastos C
Neurologia; 2013; 28(9):550-7. PubMed ID: 23274119
[TBL] [Abstract][Full Text] [Related]
39. Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012.
Roth J; Roach ES; Bartels U; Jóźwiak S; Koenig MK; Weiner HL; Franz DN; Wang HZ
Pediatr Neurol; 2013 Dec; 49(6):439-44. PubMed ID: 24138953
[TBL] [Abstract][Full Text] [Related]
40. Consistent nuclear expression of thyroid transcription factor 1 in subependymal giant cell astrocytomas suggests lineage-restricted histogenesis.
Hewer E; Vajtai I
Clin Neuropathol; 2015; 34(3):128-31. PubMed ID: 25669749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
